These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

773 related articles for article (PubMed ID: 28053038)

  • 1. Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate.
    Yang T; Li S; Xu H; Walsh DM; Selkoe DJ
    J Neurosci; 2017 Jan; 37(1):152-163. PubMed ID: 28053038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
    Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ
    Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble Aβ oligomers impair hippocampal LTP by disrupting glutamatergic/GABAergic balance.
    Lei M; Xu H; Li Z; Wang Z; O'Malley TT; Zhang D; Walsh DM; Xu P; Selkoe DJ; Li S
    Neurobiol Dis; 2016 Jan; 85():111-121. PubMed ID: 26525100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusible, highly bioactive oligomers represent a critical minority of soluble Aβ in Alzheimer's disease brain.
    Hong W; Wang Z; Liu W; O'Malley TT; Jin M; Willem M; Haass C; Frosch MP; Walsh DM
    Acta Neuropathol; 2018 Jul; 136(1):19-40. PubMed ID: 29687257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers.
    Xu H; Gelyana E; Rajsombath M; Yang T; Li S; Selkoe D
    J Neurosci; 2016 Aug; 36(35):9041-56. PubMed ID: 27581448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
    Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
    Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aβ oligomers from human brain impair mossy fiber LTP in CA3 of hippocampus, but activating cAMP-PKA and cGMP-PKG prevents this.
    Jin SX; Liu L; Li S; Meunier AL; Selkoe DJ
    Neurobiol Dis; 2022 Oct; 172():105816. PubMed ID: 35820646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau and Amyloid β Protein in Patient-Derived Aqueous Brain Extracts Act Concomitantly to Disrupt Long-Term Potentiation
    Ondrejcak T; Klyubin I; Hu NW; O'Malley TT; Corbett GT; Winters R; Perkinton MS; Billinton A; Prenderville JA; Walsh DM; Rowan MJ
    J Neurosci; 2023 Aug; 43(32):5870-5879. PubMed ID: 37491315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers.
    Townsend M; Shankar GM; Mehta T; Walsh DM; Selkoe DJ
    J Physiol; 2006 Apr; 572(Pt 2):477-92. PubMed ID: 16469784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory.
    Shankar GM; Li S; Mehta TH; Garcia-Munoz A; Shepardson NE; Smith I; Brett FM; Farrell MA; Rowan MJ; Lemere CA; Regan CM; Walsh DM; Sabatini BL; Selkoe DJ
    Nat Med; 2008 Aug; 14(8):837-42. PubMed ID: 18568035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactive human Alzheimer brain soluble Aβ: pathophysiology and therapeutic opportunities.
    Li S; Stern AM
    Mol Psychiatry; 2022 Aug; 27(8):3182-3191. PubMed ID: 35484241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LTP and memory impairment caused by extracellular Aβ and Tau oligomers is APP-dependent.
    Puzzo D; Piacentini R; Fá M; Gulisano W; Li Puma DD; Staniszewski A; Zhang H; Tropea MR; Cocco S; Palmeri A; Fraser P; D'Adamio L; Grassi C; Arancio O
    Elife; 2017 Jul; 6():. PubMed ID: 28696204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-beta oligomers.
    Gandy S; Simon AJ; Steele JW; Lublin AL; Lah JJ; Walker LC; Levey AI; Krafft GA; Levy E; Checler F; Glabe C; Bilker WB; Abel T; Schmeidler J; Ehrlich ME
    Ann Neurol; 2010 Aug; 68(2):220-30. PubMed ID: 20641005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mechanistic hypothesis for the impairment of synaptic plasticity by soluble Aβ oligomers from Alzheimer's brain.
    Li S; Selkoe DJ
    J Neurochem; 2020 Sep; 154(6):583-597. PubMed ID: 32180217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP.
    Wang Z; Jackson RJ; Hong W; Taylor WM; Corbett GT; Moreno A; Liu W; Li S; Frosch MP; Slutsky I; Young-Pearse TL; Spires-Jones TL; Walsh DM
    J Neurosci; 2017 Dec; 37(49):11947-11966. PubMed ID: 29101243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain interstitial oligomeric amyloid β increases with age and is resistant to clearance from brain in a mouse model of Alzheimer's disease.
    Takeda S; Hashimoto T; Roe AD; Hori Y; Spires-Jones TL; Hyman BT
    FASEB J; 2013 Aug; 27(8):3239-48. PubMed ID: 23640054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Alzheimer's disease model mouse specialized for analyzing the function and toxicity of intraneuronal Amyloid β oligomers.
    Ochiishi T; Kaku M; Kiyosue K; Doi M; Urabe T; Hattori N; Shimura H; Ebihara T
    Sci Rep; 2019 Nov; 9(1):17368. PubMed ID: 31757975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients.
    Fukumoto H; Tokuda T; Kasai T; Ishigami N; Hidaka H; Kondo M; Allsop D; Nakagawa M
    FASEB J; 2010 Aug; 24(8):2716-26. PubMed ID: 20339023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secreted amyloid β-proteins in a cell culture model include N-terminally extended peptides that impair synaptic plasticity.
    Welzel AT; Maggio JE; Shankar GM; Walker DE; Ostaszewski BL; Li S; Klyubin I; Rowan MJ; Seubert P; Walsh DM; Selkoe DJ
    Biochemistry; 2014 Jun; 53(24):3908-21. PubMed ID: 24840308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid beta-protein dimers rapidly form stable synaptotoxic protofibrils.
    O'Nuallain B; Freir DB; Nicoll AJ; Risse E; Ferguson N; Herron CE; Collinge J; Walsh DM
    J Neurosci; 2010 Oct; 30(43):14411-9. PubMed ID: 20980598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.